Cargando…
Precision Medicine with TGF-β Inhibition Using Tumor Explants: Comment on “Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor” by N. Sumru Bayin et al.
In a new report, Bayin et al. described an ex vivo explant model to test the patient-specific response to transforming growth factor-β inhibition in high-grade gliomas.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156519/ https://www.ncbi.nlm.nih.gov/pubmed/27978995 http://dx.doi.org/10.1016/j.neo.2016.10.009 |
| Sumario: | In a new report, Bayin et al. described an ex vivo explant model to test the patient-specific response to transforming growth factor-β inhibition in high-grade gliomas. |
|---|